Faktor-faktor yang Mempengaruhi Kepatuhan Minum Obat pada Penderita TB Paru
Article Sidebar
Main Article Content
Abstract
Di seluruh dunia, Tuberkulosis (TB) adalah salah satu dari sepuluh penyebab utama kematian dan terus menjadi ancaman kesehatan global yang signifikan. Terapi infeksi TB dengan OAT bertujuan untuk menurunkan angka morbiditas dan mortalitas. Terapi OAT harus dijalani 6 bulan oleh pasien dengan TB Paru. Oleh karena itu penggunaan OAT memerlukan tingkat kepatuhan yang tinggi untuk mencapai keberhasilan terapi dan mencegah resistensi penggunaan obat. Penelitian ini bertujuan untuk mengembangkan dan memperbaharui pengetahuan terkait faktor factor yang mempengaruhi kepatuhan minum obat pada penderita TB Paru. Penelitian merupakan Systematic review menggunakan referensi Google Scholars, PubMed dan ScienceDirect dari jurnal 5 tahun terakhir. Menggunakan format PICO untuk kriteria inklusi dan eksklusi artikel. Hasil telaah menunjukkan faktor-faktor yang mempengaruhi kepatuhan minum obat pada penderita TB Paru yaitu stigma masyarakat, dukungan keluarga, pengetahuan, pendapatan, lama pengobatan dan hubungan dengan pelayan kesehatan
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Organization WH. WHO guidelines on tuberculosis infection prevention and control. 2019 update.
Gebreweld FH, Kifle MM, Gebremicheal FE, Simel LL, Gezae MM, Ghebreyesus SS, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):1. doi: 10.1186/s41043-017-0132-y.
Giovanni Battista Migliori LDA, Rosella Centis,, Martin Van Den Boom SE, Masoud Dara Guiding Principles to Reduce Tuberculosis Transmission in the WHO European Region, 2018
Vera V, Rahardjo SS, Murti B. Health belief model and PRECEDE PROCEED on the risk factors of multidrug resistant tuberculosis in Surakarta. Central Java J Epidemiol Public Health. 2017;2(3):241–254. doi: 10.26911/jepublichealth.2017.02.03.06.
Valencia S, Leon M, Losada I, Sequera VG, Fernandez Quevedo M, Garcia-Basteiro AL. How do we measure adherence to anti-tuberculosis treatment? Expert Rev Anti-infective Therapy. 2017;15(2):157–165. doi: 10.1080/14787210.2017.1264270.
Tola HH, Karimi M, Yekaninejad MS. Effects of socio-demographic characteristics and patients' health beliefs on tuberculosis treatment adherence in Ethiopia: a structural equation modelling approach. Infect Diseases Poverty. 2017;6(1):167. doi: 10.1186/s40249-017-0380-5.
Tola HH, Garmaroudi G, Shojaeizadeh D, Tol A, Yekaninejad MS, Ejeta LT, et al. The effect of psychosocial factors and patients' perception of tuberculosis treatment non-adherence in Addis Ababa, Ethiopia. Ethiop J Health Sci. 2017;27(5):447–448. doi: 10.4314/ejhs.v27i5.2.
Gebremariam, R. B., Wolde, M., & Beyene, A. (2021). Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar city administration, Northwest, Ethiopia: based on health belief model perspective. Journal of health, population, and nutrition, 40(1), 49. https://doi.org/10.1186/s41043-021-00275-6
Qiu L., Tong Y., Lu Z., Gong Y., Yin X. Depressive Symptoms Mediate the Associations of Stigma with Medication Adherence and Quality of Life in Tuberculosis Patients in China. Am J Trop Med Hyg. 2019;100(1):31–36. doi: 10.4269/ajtmh.18-0324.
Dos Santos APC, Lazzari TK, Silva DR, 2017. Health-related quality of life, depression and anxiety in hospitalized patients with tuberculosis. Tuberc Respir Dis (Seoul) 80: 69–76.
Mekonnen HS, Azagewa AW. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 2018;11:691. doi: 10.1186/s13104-018-3789-4.
Du, L., & Zhou, L. (2020). Determinants of Medication Adherence for Pulmonary Tuberculosis Patients During Continuation Phase in Dalian , Northeast China, 1119– 1128.
Elstob T, Plummer D, Dowi R, Wamagi S, Gula B, Siwaeya K, Pelowa D, Siba P, Warner J. The social determinants of tuberculosis treatment adherence in a remote region of Papua New Guinea. BMC Public Health. 2017;17:70. doi: 10.1186/s12889-016-3935-7.
Boru C, Shimels T, Bilal A. Factors contributing to non-adherence with treatment among TB patients in SodoWoreda, Gurage Zone, Southern Ethiopia: a qualitative study. J Infect Public Health. 2017; 10.1016/j.jiph.2016.11.018.
Gebrezgi M, Trepka M, Kidane A. Barriers to and facilitators of hypertension management in Asmara, Eritrea: patients’ perspectives. J Health Popul Nutr. 2017;36:11. doi: 10.1186/s41043-017-0090-4.
Kastien-Hilka T., Rosenkranz B., Schwenkglenks M., Bennett B.M., Sinanovic E. Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa. Front Pharmacol. 2017;8:919. doi: 10.3389/fphar.2017.00919
Yamini K, Rao B, Valleswary K. Socio-demographic determinants of health care seeking behaviour among tuberculosis patients admitted in the isolation ward of tertiary care hospital: a health belief model. Int J Community Med Public Health. 2017;4(12):4668–4675. doi: 10.18203/2394-6040.ijcmph20175348.
Azizi N, Karimy M, Salahshour VN. Determinants of adherence to tuberculosis treatment in Iranian patients: application of health belief model. J Infect Dev Ctries. 2018;12(09):706–711. doi: 10.3855/jidc.9653.
Rehemah N. Factors influencing adherence to tuberculosis treatment among pulmonary tuberculosis patients attending mpigi general hospital - Mpigi district. 2017.
Yadav, R. K., Kaphle, H. P., Yadav, D. K., Marahatta, S. B., Shah, N. P., Baral, S., Khatri, E., & Ojha, R. (2021). Health related quality of life and associated factors with medication adherence among tuberculosis patients in selected districts of Gandaki Province of Nepal. Journal of clinical tuberculosis and other mycobacterial diseases, 23, 100235. https://doi.org/10.1016/j.jctube.2021.100235
WHO. Global Tuberculosis Report 2019 [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Jan 26]. Available from: http://www.who.int/tb/publications/global_report/en/.
NTC. National Tuberculosis Program Nepal, Annual Report 2074/75 [Internet]. Thimi, Bhaktapur, Nepal: National TB Centre; 2019. Available from: https://nepalntp.gov.np/wp-content/uploads/2019/03/NTP-Annual-Report-2074-75-Up.pdf.
Salehitali S., Noorian K., Hafizi M., Dehkordi A.H. Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS) J Clin Tuberc Mycobact Dis [Internet]. 2019;15:100093. doi: 10.1016/j.jctube.2019.100093.
Malik M., Nasir R., Hussain A. Health Related Quality of Life among TB Patients: Question Mark on Performance of TB DOTS in Pakistan. J Trop Med. 2018;2018:1–7. doi: 10.1155/2018/2538532.
Siddiqui A.N., Khayyam K.U., Siddiqui N., Sarin R., Sharma M. Diabetes prevalence and its impact on health-related quality of life in tuberculosis patients. Trop Med Int Health TM IH. 2017;22(11):1394–1404. doi: 10.1111/tmi.12968.
Lee LY, Tung HH, Chen SC, Fu CH, 2017. Perceived stigma and depression in initially diagnosed pulmonary tuberculosis patients. J Clin Nurs 26: 4813–4821.
Harel O, Mitchell EM, Perkins NJ, Cole SR, Tchetgen Tchetgen EJ, Sun B, Schisterman EF, 2018. Multiple imputation for incomplete data in epidemiologic studies. Am J Epidemiol 187: 576–584
Li CT, Chu KH, Reiher B, Kienene T, Chien LY, 2017. Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati. J Int Med Res 45: 610–620.
Li Y, Zhang S, Zhang T, et al. Chinese health literacy scale for tuberculosis patients: a study on development and psychometric testing. BMC Infect Dis. 2019;19(1):545. doi: 10.1186/s12879-019-4168-z
Park S, Sentissi I, Gil SJ, et al. Medication event monitoring system for infectious tuberculosis treatment in Morocco: a retrospective cohort study. Int J Environ Res Public Health. 2019;16(3):412.